JoelRaichlenMD
Cardiology • Bryn Mawr, PAEchocardiography, Nuclear Cardiology, Cardiothoracic Imaging, Non-Invasive Cardiology
Physician
Dr. Raichlen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Hoffman Dr
Bryn Mawr, PA 19010Phone+1 610-525-5004
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1980 - 1982
Temple University HospitalResidency, Internal Medicine, 1977 - 1980
Perelman School of Medicine at the University of PennsylvaniaClass of 1977
Certifications & Licensure
PA State Medical License 1979 - 2024
NJ State Medical License 1998 - 2011
DE State Medical License 1997 - 2009
NY State Medical License 1998 - 2009
DC State Medical License 2003 - 2008
OH State Medical License 1998 - 2008
VA State Medical License 1997 - 2008- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- Join now to see all
Awards, Honors, & Recognition
- Fellow (FAHA) American Heart Association
- Fellow (FACP) American College of Physicians
- Fellow (FACC) American College of Cardiology
Clinical Trials
Publications & Presentations
PubMed
- 18 citationsLDL extracellular vesicle coagulation protein levels change after initiation of statin therapy. Findings from the METEOR trial.Laura Verbree-Willemsen, Ya-Nan Zhang, Crystel M. Gijsberts, Arjan H. Schoneveld, Jiong-Wei Wang
International Journal of Cardiology. 2018-11-15 - Response by Kusters et al to Letter Regarding Article, "Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholestero...D. Meeike Kusters, Marjet J. A. M. Braamskamp, Gisle Langslet, Brian W. McCrindle, David Cassiman
Circulation. 2018-02-06 - 36 citationsLipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURNRishi Puri, Christie M. Ballantyne, Ron C. Hoogeveen, Mingyuan Shao, Philip J. Barter
Atherosclerosis. 2017-08-01
Authored Content
- LDL Extracellular Vesicle Coagulation Protein Levels Change After Initiation of Statin Therapy. Findings from the METEOR TrialMay 2018
Professional Memberships
- Fellow
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
